Biocon Biologics offers 15% stake to SII subsidiary for 100 mn vax doses
Bengaluru, Sep 17 : Biocon Biologics, a subsidiary of Biocon, on Thursday offered approximately 15 per cent stake to Serum Institute Life Sciences (SILS) for 100 million doses of vaccines in a strategic alliance.SILS is a subsidiary of Pune-based Ser…